Skip to main content

Table 1 Patient characteristics (n = 184)

From: Patients’ perceptions of palliative care: adaptation of the Quality from the Patient’s Perspective instrument for use in palliative care, and description of patients’ perceptions of care received

 

n (%)

Missing

Age (years)

 

7

 Mean age (SD), range

66.51 (11.71), 41–94

 

Gender

 

3

 Female

101 (55.8)

 

 Male

80 (44.2)

 

Education

 

5

 Primary school or equivalent

44 (24.6)

 

 High school or equivalent

69 (38.5)

 

 University/university college

66 (36.9)

 

First language

 

1

 Norwegian

171 (93.4)

 

 Sami

0

 

 Other Nordic language

3 (1.6)

 

 Other European language

8 (4.4)

 

 Non-European language

1 (0.5)

 

Type of illness

 

1

 Malignant illness (cancer)

139 (76.0)

 

 Non-malignant illness (e.g. COPD, HF, MS, ALS, Parkinson’s disease)

29 (15.8)

 

 Mixed malignant and non-malignant illnesses

15 (8.2)

 

Number of illnesses

 

1

 One diagnosis

128 (69.9)

 

 Two or more illnesses

55 (30.1)

 

Setting

  

 Hospice inpatient care

69 (37.5)

 

 Hospice day care

51 (27.7)

 

 Palliative care units in nursing homes

29 (15.8)

 

 Home care

35 (19.0)

 

Time in care (days)

 

11

 3–7 days

30 (17.3)

 

 8–30 days

51 (29.5)

 

 31–182 days (1–6 months)

47 (27.2)

 

  > 183 (6 months)

45 (26.0)

 

Living conditions

 

1

 Living alone

95 (51.9)

 

 Living with a partner

69 (37.7)

 

 Living with children aged <18 years

11 (6.8)

 

 Living with others

8 (4.4)

 

The amount of contact with family or friends

 

1

 Daily

107 (58.5)

 

 Several times a week

62 (33.9)

 

 Once a week to once a month

14 (7.7)

 

 Less than once a month

0

 

 No contact with family or friends

0

 

The sufficiency of contact with family or friends

 

1

 Too often

5 (2.7)

 

 Sufficient

155 (84.7)

 

 Too seldom

23 (12.6)

 

Religious affiliation

 

12

 No

90 (52.3)

 

 Yes

82 (47.7)

 
  1. For categorical variables n (%) is presented. For continuous variables mean (SD) and range are presented
  2. ALS, amyotrophic lateral sclerosis; COPD, chronic obstructive pulmonary disorder; HF, heart failure; MS, multiple sclerosis